Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cipla

Cipla

BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 19, 16:00
584.20
0.35 (0.06%)
VOLUME 48,118
LIVE
NSE
Apr 19, 15:59
584.40
-0.2 (-0.03%)
VOLUME 1,525,419
News on Cipla
Select Year: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Cipla may test Rs 650 on robust Q4FY18 results: Akash Jain

2.06 pm | 17 Apr 2018 |  Source: Moneycontrol.com

"The company is fairly valued at current market price. However, if Q4FY18 results are robust then we can expect a target of Rs 650 by FY19 end," says ...

Buy Cipla, target Rs 650: S Ranganathan

12.39 pm | 17 Apr 2018 |  Source: Moneycontrol.com

"Its respiratory platform will be the key driver in scaling up its US business trajectory even as its India continues to grow at double-digits. We hav...

Stocks in the news: Cipla, Bajaj Electricals, Fortis Health, RComm, Adani Ports, CRISIL, Tata Sponge

7.48 am | 17 Apr 2018 |  Source: Moneycontrol.com

Bajaj Electricals, Fortis Healthcare, Reliance Communications, Adani Ports, CRISIL, Muthoot Capital, Orchid Pharma and Tata Sponge Iron are the stocks...

USFDA conducts inspection at Cipla's Indore facility

9.05 pm | 16 Apr 2018 |  Source: PTI

"The United States Food and Drug Administration (USFDA) conducted a routine current Good Manufacturing Practices (cGMP) audit at its Indore formulatio...

Cipla Q4 PAT seen up 57.7% YoY to Rs. 322 cr: Edelweiss

5.58 pm | 16 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 6.2 percent Y-o-Y (down 2.8 percent Q-o-Q) to Rs. 3,805.3 crore, according to Edelweiss....

Cipla gains 5% after USFDA inspection with no data integrity or repeat observations

12.58 pm | 16 Apr 2018 |  Source: Moneycontrol.com

The US Food and Drug Administration has recently completed its inspection of Cipla's Indore facility....

Cipla rises 1% on launching authorized generic of Aloxi in US market

1.42 pm | 26 Mar 2018 |  Source: Moneycontrol.com

Cipla USA, Inc. has launched an authorized generic version of Aloxi in the United States under applicable agreements with Helsinn Healthcare SA, in re...

Cipla launches Aloxi generic in US market under agreement with Helsinn 

10.22 am | 26 Mar 2018 |  Source: CNBC-TV18

It is a positive news for Cipla. They will be launching Aloxi generic which is used for nausea which is induced due to chemotherapy as an authorised g...

Cipla launches authorized generic of Aloxi

9.35 am | 26 Mar 2018 |  Source: Moneycontrol.com

Cipla USA announced the launch of an authorized generic version of Aloxi in the United States under applicable agreements with Helsinn Healthcare SA, ...

News Highlights: Ola cabs strike ends, Uber strike to continue in Mumbai

11.55 am | 21 Mar 2018 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Cipla gets USFDA observations for its Goa plant

8.48 pm | 20 Mar 2018 |  Source: PTI

The United States Food and Drug Administration (USFDA) had conducted a product specific pre-approval inspection at company's Goa plant in January ...

The top buzzing midcap stocks to trade on March 19

1.13 pm | 20 Mar 2018 |  Source: CNBC-TV18

Here are some of the top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. Keep an eye on Cipla, Elpro International, Gujarat S...

Know more about USFDA's observations to Cipla's Goa unit 

12.38 pm | 20 Mar 2018 |  Source: CNBC-TV18

CNBC-TV18 accesses US FDA observations to Cipla’s Goa Unit. Watch accompanying video of CNBC-TV18’s Ekta Batra for more details....

Sell Cipla, BEML; Buy NIIT Technologies: Ashwani Gujral 

11.28 am | 20 Mar 2018 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com advises selling Cipla and BEML....

Cipla shares trim losses after company clarifies on USFDA observations for Goa unit

10.12 am | 20 Mar 2018 |  Source: Moneycontrol.com

Cipla told CNBC-TV18 the Goa unit observations are procedural & addressable in nature....

Hold Cipla; target of Rs 653: Geojit

3.52 pm | 21 Feb 2018 |  Source: Moneycontrol.com

Geojit recommended hold rating on Cipla with a target price of Rs 653 in its research report dated February 21, 2018....

Buy Cipla; target of Rs 714: KR Choksey

4.49 pm | 08 Feb 2018 |  Source: Moneycontrol.com

KR Choksey is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 714 in its research report dated February 08, 2018....

US, India will continue to outperform going ahead: Cipla 

11.57 am | 08 Feb 2018 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Kedar Upadhye, Group CFO of Cipla spoke about the results and his outlook for the company....

Cipla Q3 profit grows 5% on better operational show, tax reversal 

2.12 pm | 07 Feb 2018 |  Source: Moneycontrol.com

Operating profit at Rs 818.7 crore and margin at 20.9 percent were ahead of estimates of Rs 791 crore and 19.3 percent, respectively....

Buy Cipla; target of Rs 700: Centrum

5.03 pm | 16 Nov 2017 |  Source: Moneycontrol.com

Centrum is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 700 in its research report dated November 07, 2017....

1 2 3
Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.